Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial
- 1 August 2020
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (3), 393-401
- https://doi.org/10.1164/rccm.202002-0328oc
Abstract
Rationale: Idiopathic pulmonary fibrosis (IPF) is a deadly disease with increasingly impaired health-related quality of life (HRQOL). EHealth technologies facilitate collection of physiological outcomes and patient reported-outcomes (PROMs) at home, but randomized controlled trials (RCTs) on the effects of eHealth are scarce. We investigated whether a home monitoring program improved HRQOL and medication use for IPF patients. Methods: We performed a multicenter RCT in newly treated patients with IPF. Patients were randomly assigned to standard care or a home monitoring program on top of standard care for 24 weeks. The home monitoring program included home spirometry, reporting of symptoms and side-effects, PROMs, information, a medication coach and eConsultations. The primary endpoint was between-group difference in change in Kings Brief Interstitial Lung disease (K-BILD) questionnaire score at 24 weeks. Results: 90 patients were randomized (46 patients home monitoring, 44 standard care). After 24 weeks, no statistically significant differences were found in K-BILD total score (home monitoring group:+2.7 points, standard care:+0.03, p=0.24) and psychological domain score (home monitoring group:+5.1, standard care:-0.5, p=0.1). In the home monitoring group medication was more often adjusted (1 vs 0.3 adjustments per patient, p=0.027). Patient satisfaction with the home monitoring program was high. Home-based spirometry was highly correlated with hospital-based spirometry over time. Conclusions: The results of this first-ever eHealth RCT in IPF showed that a comprehensive home monitoring program did not improve overall HRQOL measured with K-BILD, but tended to improve psychological wellbeing. Home monitoring was greatly appreciated by patients and allowed for individually-tailored medication adjustments. Clinical trial registration available at www.clinicaltrials.gov, ID: NCT03420235.Keywords
This publication has 27 references indexed in Scilit:
- Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Interactive digital interventions to promote self-management in adults with asthma: systematic review and meta-analysisBMC Pulmonary Medicine, 2016
- Do telemedical interventions improve quality of life in patients with COPD? A systematic reviewInternational Journal of Chronic Obstructive Pulmonary Disease, 2016
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisThe New England Journal of Medicine, 2014
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisThe New England Journal of Medicine, 2014
- The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaireThorax, 2012
- Development and Testing of a Short Form of the Patient Activation MeasureHealth Services Research, 2005
- EuroQol: the current state of playHealth Policy, 1996
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- The Structure of CopingJournal of Health and Social Behavior, 1978